Why the study?
Does moderate alcohol intake improve mortality and cardiovascular risk in patients with NIDDM?
Does moderate alcohol intake improve mortality and cardiovascular risk in patients with NIDDM?
Moderate alcohol consumption (1-3 drinks per day) may offer cardiovascular benefits for NIDDM patients through improved insulin resistance and lipid profiles, though heavy intake carries significant metabolic and systemic risks.
Associations in diabetes may support moderate intake; leaves open confirmation by randomized trials before any practice shift.
Historically, alcohol use by the diabetic patient has been controversial. Recent studies in the general population have shown an improvement in mortality with moderate alcohol intake (one to three drinks per day). This improved mortality is greatest in those individuals who have a higher risk of ischemic heart disease. The mechanisms of the beneficial effects of alcohol include positive effects on insulin resistance, HDL cholesterol, platelet aggregation, and fibrinolysis. Since the diabetic patient has an especially high risk of ischemic heart disease because of these factors, the use of a moderate amount of alcohol should not be discouraged. The short-term risks of heavy or continuous alcohol intake include hypoglycemia, glucose intolerance, and ketone and lactate accumulation. In the long term, heavy alcohol intake is associated with an increased prevalence of cancer, hypertension, cirrhosis of the liver, and symptomatic neuropathy. Moderate alcohol intake taken with a meal has been shown to have little or no effect on postprandial glycemic excursions.
No takes yet. Share an insight, caveat, or question.
David S.H. Bell (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: